China, as the one of the largest developing countries in the world and with about one‐fifth of
the global population, is bearing an increasing burden on health from cancer. In the area of …

Opinion statement Esophageal cancer is a leading cause of cancer deaths worldwide, with
an increasing incidence in recent decades. The majority of esophageal cancers are …

Objective This study aimed to analyze whether involved field irradiation (IFI) is associated
with improving survival outcomes and reducing adverse events compared with elective …

Background Immunotherapy has become the standard of treatment for recurrent metastatic
esophageal cancer (EC), and the value of efficacy predictive markers represented by …

Introduction To determine the effect of statin use during concurrent chemoradiotherapy
(CCRT) on overall survival and esophageal squamous cell carcinoma (ESCC)-specific …

Purpose To compare the differences between involved-field irradiation (IFI) and elective
nodal irradiation (ENI) in selecting the optimal target area for neoadjuvant …

Background Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally
advanced esophageal squamous cell carcinoma (ESCC). However, the optimal …

Introduction Locally advanced esophageal cancer (EC) has poor prognosis. Preliminary
clinical studies have demonstrated the synergistic efficacy of radiotherapy combined with …

Esophageal squamous cell carcinoma is one of the most common malignant tumors in the
digestive system in China and the world. Most patients are diagnosed as locally advanced …

Esophageal squamous cell carcinoma (ESCC) is an aggressive and fatal disease that is
usually diagnosed when the chances for surgical intervention has been missed. Definitive …